FDA
Featured FDA Content
Federal Agencies Push for Uniform Definition of ‘Ultraprocessed Food’ Amid Health Scrutiny
The FDA and USDA are collaborating to develop a federally recognized uniform definition for ultraprocessed foods (UPFs) amid mounting health concerns.
Nestle, Conagra Join Dye Phase-Out Amid State Pressure
Nestle and Conagra have joined Kraft Heinz and General Mills in pledging to remove the use of synthetic food dyes from their formulations amid growing pressure from the federal government and accelerated traction at the state level.
Is Big Food Embracing MAHA?
Starbucks is the latest to take down a red dye pill, with Robert F. Kennedy Jr. sharing details from a meeting with the coffee giant’s CEO where he “shared the company’s plans to further MAHA its menu.”
Additional Content
FDA Issues Final Guidance for Nutritional Labeling
The FDA’s new Nutrition Facts label regulations went into effect January 1 for companies with over $10 million in annual sales, and the agency issued final guidance to address questions submitted by the industry.
FDA Issues Warnings to 15 CBD Companies — and Alerts Consumers of Possible Side Effects
The FDA yesterday issued 15 warning letters to CBD companies and updated its advice for consumers to follow while regulations are developed. Citing numerous safety concerns and a lack of scientific information, FDA said it cannot recognize CBD as generally recognized as safe (GRAS) for use in human or animal food.
CBD News Roundup: McConnell Pushes for Guidelines, FTC Issues Warnings
Here are a few recent developments in the past week on the U.S. government’s plans to regulate hemp and CBD.
The Checkout: FDA Updates ‘Added Sugars’ Requirement, Thrive Removes CBD and Hemp
FDA updates ‘Added Sugars’ requirement, Thrive removes CBD and hemp and more in this week’s Checkout.
Industry Responds to FDA Hearing on Cannabis Products
The FDA’s first hearing on cannabis products provided few concrete answers on exactly how and when it will regulate the emerging marketplace of CBD products. In the following days, NOSH spoke with a handful of industry experts to assess their reactions.
FDA Holds First Hearing on Cannabis Products
For a natural remedy meant to ease anxiety, the CBD market has become a place of confusion — not calm. On Friday, the FDA held its first hearing on cannabis products, including CBD food and drink products.
Food Safety Update: FDA Announces New Initiatives, EPA Deems Glyphosate Safe
Governmental agencies made several new announcements this week that could impact how brands and suppliers approach food safety.
FDA Allows Allulose to be Excluded from Total and Added Sugars
The FDA issued new draft guidance last week for allulose, stating it intends to allow manufacturers to exclude the low-calorie sweetener from total and added sugars on Nutrition Facts labels, marking the first time a sweetener will be exempt from the total or added sugars list.
Post Qualified Health Claim Status, Allergen Introduction Market Sees Growth
Brands’ — such as Puffworks — efforts to prevent peanut allergies have inspired other brands to develop products that offer the early introduction of other allergens.
FDA to Consumers: How Would You Define Dairy?
The FDA today announced it has issued a request for information (RFI) in the Federal Register to solicit comments and feedback from the public to gain more insight into how consumers use plant-based alternatives and how they understand terms like “milk” or “cheese” when used to label plant-based products.